MA15.07 Different Responses to Osimertinib in Primary and Acquired EGFR T790m-Mutant NSCLC Patients

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search